Personalized peptide vaccine

BIOLOGICAL2 trials

Sponsors

Washington University School of Medicine

Conditions

Astrocytoma, Grade IVGlioblastoma MultiformePediatric Brain Tumor

Phase 1

Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma

TerminatedNCT02510950

Washington University School of MedicineAstrocytoma, Grade IV, Glioblastoma Multiforme

Start: 2015-12-03End: 2017-02-14Updated: 2017-11-17

Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors

WithdrawnNCT03068832

Washington University School of MedicinePediatric Brain Tumor

Start: 2021-09-30End: 2026-02-28Updated: 2021-05-25